The China Southern CSI Brand Name Drug Industry ETF seeks to replicate as closely as possible the price and yield performance of the CSI Innovative Pharmaceutical Industrial Index and invests in a portfolio comprised primarily of Chinese healthcare companies
The China Southern CSI Brand Name Drug Industry ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in China. The CSOP Asset Management fund’s base currency is CNY and the share class was registered 12.03.2021 with unique ISIN - CNE100004GW8. Main exchange is Shenzhen SE and ticker symbol is 159858. The total expense ratio is 0.2%. The China Southern CSI Brand Name Drug Industry ETF (CNY) pays dividends 1 time(s) per year.